Palmitoylated APP Forms Dimers, Cleaved by BACE1

A major rate-limiting step for Aβ generation and deposition in Alzheimer’s disease brains is BACE1-mediated cleavage (β-cleavage) of the amyloid precursor protein (APP). We previously reported that APP undergoes palmitoylation at two cysteine residues (Cys 186 and Cys 187 ) in the E1-ectodomain. 8–10% of total APP is palmitoylated in vitro and in vivo . Palmitoylated APP ( pal APP) shows greater preference for β-cleavage than total APP in detergent resistant lipid rafts. Protein palmitoylation is known to promote protein dimerization. Since dimerization of APP at its E1-ectodomain results in elevated BACE1-mediated cleavage of APP, we have now investigated whether palmitoylation of APP affects its dimerization and whether this leads to elevated β-cleavage of the protein. Here we report that over 90% of pal APP is dimerized while only ~20% of total APP forms dimers. Pal APP-dimers are predominantly cis -oriented while total APP dimerizes in both cis - and trans -orientation. Pal APP forms dimers 4.5-times more efficiently than total APP. Overexpression of the palmitoylating enzymes DHHC7 and DHHC21 that increase pal APP levels and Aβ release, also increased APP dimerization in cells. Conversely, inhibition of APP palmitoylation by pharmacological inhibitors reduced APP-dimerization in coimmunoprecipitation and FLIM/FRET assays. Finally, in vitro BACE1-activity assays demonstrate that palmitoylation-dependent dimerization of APP promotes β-cleavage of APP in lipid-rich detergent resistant cell membranes (DRMs), when compared to total APP. Most importantly, generation of sAPP β -sAPP β dimers is dependent on APP-palmitoylation while total sAPP β generation is not. Since BACE1 shows preference for pal APP dimers over total APP, pal APP dimers may serve as novel targets for effective β-cleavage inhibitors of APP as opposed to BACE1 inhibitors.